Sanctus Global Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-07-2024
- Paid Up Capital ₹ 0.10 M
as on 04-07-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -2.24%
(FY 2023)
- Profit -944.80%
(FY 2023)
- Ebitda -820.43%
(FY 2023)
- Net Worth -54.35%
(FY 2023)
- Total Assets -2.31%
(FY 2023)
About Sanctus Global Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sahil Joshi and Vijay Joshi serve as directors at the Company.
- CIN/LLPIN
U51909CH2017PTC041369
- Company No.
041369
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Feb 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sanctus Global Lifesciences Private Limited offer?
Sanctus Global Lifesciences Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Allopathic Cough Syrup, Hand Sanitizers & Personal Hygiene, Wet Wipes, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Cardiovascular Drugs & Medication, Diabetes Medicine, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Sanctus Global Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahil Joshi  | Director | 25-May-2022 | Current |
| Vijay Joshi | Director | 06-Feb-2017 | Current |
Financial Performance of Sanctus Global Lifesciences.
Sanctus Global Lifesciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.24% decrease. The company also saw a substantial fall in profitability, with a 944.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 54.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanctus Global Lifesciences?
Unlock access to Sanctus Global Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sanctus Global Formulations LimitedActive 24 years 1 monthSahil Joshi and Vijay Joshi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanctus Global Lifesciences?
Unlock and access historical data on people associated with Sanctus Global Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanctus Global Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanctus Global Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
